A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases
- PMID: 17699461
- DOI: 10.2215/CJN.04121206
A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases
Abstract
A spectrum of proteinuric glomerular diseases results from podocyte abnormalities. The understanding of these podocytopathies has greatly expanded in recent years, particularly with the discovery of more than a dozen genetic mutations that are associated with loss of podocyte functional integrity. It is apparent that classification of the podocytopathies on the basis of morphology alone is inadequate to capture fully the complexity of these disorders. Herein is proposed a taxonomy for the podocytopathies that classifies along two dimensions: Histopathology, including podocyte phenotype and glomerular morphology (minimal-change nephropathy, focal segmental glomerulosclerosis, diffuse mesangial sclerosis, and collapsing glomerulopathy), and etiology (idiopathic, genetic, and reactive forms). A more complete understanding of the similarities and differences among podocyte diseases will help the renal pathologist and the nephrologist communicate more effectively about the diagnosis; this in turn will help the nephrologist provide more accurate prognostic information and select the optimal therapy for these often problematic diseases. It is proposed that final diagnosis of the podocytopathies should result from close collaboration between renal pathologists and nephrologists and should whenever possible include three elements: Morphologic entity, etiologic form, and specific pathogenic mechanism or association.
Similar articles
-
Role of Podocyte in Kidney Disease.Front Biosci (Landmark Ed). 2024 Jul 11;29(7):250. doi: 10.31083/j.fbl2907250. Front Biosci (Landmark Ed). 2024. PMID: 39082335 Review.
-
Targeting podocyte-associated diseases.Adv Drug Deliv Rev. 2010 Nov 30;62(14):1325-36. doi: 10.1016/j.addr.2010.08.012. Epub 2010 Sep 7. Adv Drug Deliv Rev. 2010. PMID: 20828590 Review.
-
Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy.Arch Pathol Lab Med. 2009 Feb;133(2):201-16. doi: 10.5858/133.2.201. Arch Pathol Lab Med. 2009. PMID: 19195964 Free PMC article.
-
Nephrinuria and podocytopathies.Adv Clin Chem. 2022;108:1-36. doi: 10.1016/bs.acc.2021.08.001. Epub 2021 Sep 10. Adv Clin Chem. 2022. PMID: 35659057
-
Podocyte biology and the emerging understanding of podocyte diseases.Am J Nephrol. 2003 Sep-Oct;23(5):353-60. doi: 10.1159/000072917. Epub 2003 Aug 12. Am J Nephrol. 2003. PMID: 12915777 Review.
Cited by
-
Collapsing glomerulopathy following anabolic steroid use in a 16-year-old boy with IgA nephropathy.Indian J Nephrol. 2015 Mar-Apr;25(2):99-102. doi: 10.4103/0971-4065.140714. Indian J Nephrol. 2015. PMID: 25838648 Free PMC article.
-
Collapsing focal segmental glomerulosclerosis: Increasing the awareness.J Nephropathol. 2012 Jul;1(2):77-80. doi: 10.5812/nephropathol.7474. Epub 2012 Jul 5. J Nephropathol. 2012. PMID: 24475392 Free PMC article.
-
A case report of congenital nephrotic syndrome caused by new mutations of NPHS1.J Int Med Res. 2021 Aug;49(8):3000605211038133. doi: 10.1177/03000605211038133. J Int Med Res. 2021. PMID: 34396835 Free PMC article.
-
Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis?Pediatr Nephrol. 2014 Dec;29(12):2333-40. doi: 10.1007/s00467-014-2874-8. Epub 2014 Jul 14. Pediatr Nephrol. 2014. PMID: 25017621 Free PMC article.
-
SLIT2/ROBO2 signaling pathway inhibits nonmuscle myosin IIA activity and destabilizes kidney podocyte adhesion.JCI Insight. 2016 Nov 17;1(19):e86934. doi: 10.1172/jci.insight.86934. JCI Insight. 2016. PMID: 27882344 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical